STW-30404-44302
3 vaccinations
1 coded response
5 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 782 / TX
- Registered
- 2021-10-02
- Relationship
- Adult relative or friend
- Guardian
- JKM-28348-32739
- Race
- American Indian or Alaska Native
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-13
Dose 1 — Pfizer-BioNTech
-
2021-02-03
Dose 2 — Pfizer-BioNTech
-
2021-10-02
Registered in v-safe
-
2021-10-30
Dose 3 — Pfizer-BioNTech
- 2021-11-13
- 2021-12-04
- 2021-12-11
-
2022-01-29
Survey response — 3 months, dose 3, dependentMedDRA: Oropharyngeal pain, Rhinorrhoea, Wheezing — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, runny nose wheezingMedDRA releases: 2024-11 · check-in free text available
- 2022-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-13 | Pfizer-BioNTech | No |
| 2 | 2021-02-03 | Pfizer-BioNTech | No |
| 3 | 2021-10-30 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 3, dependent
Symptoms: Sore throat, runny nose wheezing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release